| Literature DB >> 30385710 |
Raphaëlle Riché1, Meijiang Liao1, Izabella A Pena2, Kit-Yi Leung3, Nathalie Lepage2, Nicolas DE Greene3, Kyriakie Sarafoglou4, Lisa A Schimmenti5,6,7, Pierre Drapeau1,8, Éric Samarut1,8.
Abstract
Glycine encephalopathy (GE), or nonketotic hyperglycinemia (NKH), is a rare recessive genetic disease caused by defective glycine cleavage and characterized by increased accumulation of glycine in all tissues. Here, based on new case reports of GLDC loss-of-function mutations in GE patients, we aimed to generate a zebrafish model of severe GE in order to unravel the molecular mechanism of the disease. Using CRISPR/Cas9, we knocked out the gldc gene and showed that gldc-/- fish recapitulate GE on a molecular level and present a motor phenotype reminiscent of severe GE symptoms. The molecular characterization of gldc-/- mutants showed a broad metabolic disturbance affecting amino acids and neurotransmitters other than glycine, with lactic acidosis at stages preceding death. Although a transient imbalance was found in cell proliferation in the brain of gldc-/- zebrafish, the main brain networks were not affected, thus suggesting that GE pathogenicity is mainly due to metabolic defects. We confirmed that the gldc-/- hypotonic phenotype is due to NMDA and glycine receptor overactivation, and demonstrated that gldc-/- larvae depict exacerbated hyperglycinemia at these synapses. Remarkably, we were able to rescue the motor dysfunction of gldc-/- larvae by counterbalancing pharmacologically or genetically the level of glycine at the synapse.Entities:
Keywords: Amino acid metabolism; Genetics; Neurological disorders; Neuroscience
Mesh:
Substances:
Year: 2018 PMID: 30385710 PMCID: PMC6238748 DOI: 10.1172/jci.insight.124642
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708